Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Get effective polyclonal antisera in one month.

Yuan Xin Hu1, Ju Yuan Guo, Lu Shen

  • 1State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.

Cell Research
|July 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GGC expansions in NOTCH2NLC contribute to Parkinson disease and dopaminergic neuron degeneration.

European journal of neurology·2023
Same author

Visible-Light-Induced Cascade Cyclization of 1-Acryloyl-2-cyanoindole: Access of Difluoroalkylated Pyrrolo[1,2-<i>a</i>]indolediones.

The Journal of organic chemistry·2023
Same author

Mutation and clinical analysis of the CLCC1 gene in amyotrophic lateral sclerosis patients from Central South China.

Annals of clinical and translational neurology·2023
Same author

A detection model of cognitive impairment via the integrated gait and eye movement analysis from a large Chinese community cohort.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2023
Same author

Association of TRMT2B gene variants with juvenile amyotrophic lateral sclerosis.

Frontiers of medicine·2023
Same author

Metformin regulates the LIN28B‑mediated JNK/STAT3 signaling pathway through miR‑140‑3p in subretinal fibrosis.

Experimental and therapeutic medicine·2023

This study introduces a faster method for producing high-titer polyclonal antisera. A modified immunization protocol significantly reduces antibody production time to one month, enabling rapid use in Western blot and immunohistochemistry.

Area of Science:

  • Immunology
  • Biotechnology
  • Protein Chemistry

Background:

  • Traditional immunization protocols require 3-4 months for high-titer polyclonal antisera development.
  • Polyclonal antisera are crucial for various immunological assays like Western blot and immunohistochemistry.

Purpose of the Study:

  • To present a modified immunization procedure for accelerated polyclonal antisera production.
  • To achieve high-titer and high-avidity antisera within one month for downstream applications.

Main Methods:

  • A modified immunization protocol involving an additional injection of Freund's complete adjuvant (sample A) on day 3 post-primary immunization.
  • Standard immunization involved successive injections of Freund's incomplete adjuvant (sample B) every 2-4 weeks.

Related Experiment Videos

Main Results:

  • High-titer polyclonal antisera were obtained within one month, significantly faster than traditional methods.
  • The generated antisera demonstrated sufficient avidity for Western blot and immunohistochemistry analyses.
  • The method was validated using three recombinant antigens of varying molecular weights (5.9-55 KD) from different expression systems.

Conclusions:

  • The modified immunization strategy significantly accelerates the timeline for generating functional polyclonal antisera.
  • This expedited method provides a valuable tool for researchers needing rapid antibody production for immunological assays.
  • The protocol's effectiveness across different antigen types and molecular weights highlights its broad applicability.